Updated with Current Evidence-Based Guidelines (2023–2024) Epidemiology and Pathobiological Context Small cell lung carcinoma (SCLC) accounts for approximately 13–15% of all primary lung cancers, with an incidence declining modestly over…
Epoetin alfa is a recombinant human erythropoietin (rhEPO) that stimulates erythropoiesis. It is used in the management of anemia associated with chronic kidney disease (CKD), chemotherapy, zidovudine therapy in HIV,…
Endless studies When I was 3 years old I started studying in pre-school. Now I am a medical doctor with 10 years of experience. I am still studying every day…
MRCP - overview Membership of the Royal Colleges of Physicians of the UK is a gold standard degree in clinical medicine. A doctor with this medical degree can show a…
Apremilast is an orally administered small molecule approved for the treatment of immune-mediated inflammatory conditions. It is classified as a selective phosphodiesterase 4 (PDE4) inhibitor, with anti-inflammatory properties beneficial in…
Nivolumab is a fully human IgG4 monoclonal antibody that targets the programmed death-1 (PD-1) receptor. By modulating immune checkpoints, nivolumab enhances the body’s antitumor immune response and has transformed the…
Cabozantinib is an oral tyrosine kinase inhibitor (TKI) used in the treatment of several advanced and metastatic cancers. It inhibits multiple pathways involved in tumor growth, angiogenesis, and metastasis, making…
Keytruda® (generic: pembrolizumab) is a humanized monoclonal antibody that works as an immune checkpoint inhibitor, targeting PD-1 (programmed death-1) to restore anti-tumor immune responses. First approved by the FDA in…
1. Introduction & Mechanism of Action Ipilimumab is a humanized IgG4 monoclonal antibody that selectively binds to cytotoxic T-lymphocyte-associated protein 4 (CTLA-4), an inhibitory receptor expressed on activated T cells…
1. Pharmacological Mechanism (Expanded) Rosuvastatin is a high-potency, lipophilic statin that acts as a competitive inhibitor of 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase, the key regulatory enzyme in the hepatic cholesterol biosynthesis…
1. Introduction and Significance Sofosbuvir represents a paradigm shift in the management of chronic hepatitis C virus (HCV) infection, particularly since its approval by the FDA in 2013. As a…
1. Introduction Dasatinib (brand name Sprycel) is a second-generation, reversible tyrosine kinase inhibitor (TKI) primarily used in the management of Philadelphia chromosome-positive (Ph+) chronic myeloid leukemia (CML) and Philadelphia chromosome-positive…
1. Introduction Valcyte® (valganciclovir) is a prodrug of ganciclovir, primarily indicated for the prophylaxis and treatment of cytomegalovirus (CMV) infections in immunocompromised patients, particularly those with acquired immunodeficiency syndrome (AIDS)…
Overview Bupivacaine (brand names include Marcaine®) is a long-acting local anesthetic belonging to the amide class of local anesthetics. It is widely used in regional anesthesia, including peripheral nerve blocks,…
Overview Riociguat (Adempas®), developed by Bayer, is a first-in-class oral soluble guanylate cyclase (sGC) stimulator approved in multiple jurisdictions for the management of pulmonary hypertension (PH). It is indicated for…
